Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-006734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-03 | CAPR | Bergmann Anthony | CFO | M - OptEx | $1.39 | +2,500 | 8,223 | +44% | +$3,475 |
| D | 2025-03-04 | 2025-03-03 | CAPR | Bergmann Anthony | CFO | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | M | A | 2,500 | $1.39 | 8,223 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-03 | M | D | 2,500 | $0.00 | 0 | D | $1.39 · — to 2025-03-03 | 2,500 Common Stock | (F1) This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F2) Shares vested 1/48th on the first day of each month commencing April 1, 2015. |